Brondino N

Department of Brain and Behavioural Sciences, University of Pavia

12 papers · 2 preprints · ORCID

ArticleKetamine

Glutamatergic Resonance and Dopaminergic Stability: Intranasal Esketamine in Treatment-Resistant Depression with Comorbid ADHD and Autism Spectrum Disorder – A Case Report

Angeletti M, La Monica K, Casati V +9

Europe PMC2026
ArticleKetamine

Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopathological Reflections

Casati V, La Monica K, Angeletti M +11

Europe PMC2026
ArticleKetamine

Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression

Versaci G, Olivola M, La Monica K +11

Europe PMC2026
ArticleKetamine

Dissociation Does Not Mediate Antidepressant Response to Esketamine: A Real-World Longitudinal Study with 6-Month Follow-Up

Olivola M, Martiadis V, La Monica K +8

Europe PMC2026
ArticleKetamine

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports.

Guffanti A, Leonardi M, Brondino N +3

Europe PMC2026
ArticleKetamine

Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study.

Olivola M, Prodi T, Versaci G +9

Europe PMC2026
ArticleKetamine

Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality.

Olivola M, Mazzoni F, Tarantino B +12

Europe PMC2025
PreprintKetamine

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports

Guffanti A, Leonardi M, Brondino N +3

Europe PMC2026
ArticleKetamine

Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study.

Leonardi M, Frediani A, Angeletti MC +10

Europe PMC2025
PreprintKetamine

Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study, Predictor Analysis and Clinical Implications

Leonardi M, Frediani A, Angeletti MC +10

Europe PMC2025
ArticleKetamine

Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study.

Olivola M, Mazzoni F, Tarantino B +11

Europe PMC2026
ArticleKetamine

Depression and suicidal risk in autism spectrum disorder: efficacy of intranasal esketamine. Clinical experience from a public mental health service in Italy

Guffanti A, Mazzoni F, Silva A +4

Europe PMC2025
ArticleKetamine

“Improvements in Reflective Functioning in Patients with Treatment-Resistant Depression and Personality Disorder Treated with Esketamine”

Olivola M, Mazzoni F, Alessandro G +3

Europe PMC2025
ArticleKetamine

Esketamine for resistant depression in older people with cognitive impairment: a case report

Mazzoni F, Arienti V, Civardi S +6

Europe PMC2024